Latest News about GILD
Recent news which mentions GILD
This Biotech Stock Is Too Cheap to Ignore
July 29, 2021
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
From InvestorPlace
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
From Benzinga
From InvestorPlace
3 Biotechs That Could Make Big Acquisitions This Year
July 22, 2021
From Motley Fool
From MarketWatch
Four-Year Biktarvy Data Show High Efficacy, Durable Viral Suppression In Untreated HIV Patients
July 19, 2021
Tickers
GILD
From Benzinga
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
July 19, 2021
Tickers
GILD
From Benzinga
2 Top Pharma Stocks to Buy Right Now
July 18, 2021
From Motley Fool
Moderna Is Now More Valued Than Gilead, GlaxoSmithKline: How Long Did COVID-19 Vaccine Maker Take To Hit $100B?
July 15, 2021
From Benzinga
Investing $72,036 Into These 3 Stocks Can Generate $300 in Monthly Income for Your Portfolio
July 14, 2021
From Motley Fool
5 Stocks to Own for the Surge in Coronavirus Variants
July 14, 2021
From Motley Fool
Gilead's Remdesivir Fails To Show Antiviral Effects Against COVID-19 In Small WHO Study
July 13, 2021
Tickers
GILD
From Benzinga
From Motley Fool
2 Top Global Value Stocks to Buy Now
July 08, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.